MicroRNAs (miRNAs) are endogenously encoded small RNAs of \~22 nucleotides in length that play important roles in a large diversity of biological processes^[@R1],[@R2],[@R3]^. Genetic studies have shown that miRNAs are important regulators in the immune system^[@R4],[@R5]^. However, the functions of individual miRNAs during lymphocyte development and effector cell differentiation remain largely unknown. miR-17\~92, miR-106a\~363, and miR-106b\~25 are members of a family of highly conserved miRNAs, the miR-17\~92 family^[@R6]^. Together, these three clusters encode for thirteen distinct miRNAs, which belong to four miRNA subfamilies (miR-17, miR-18, miR-19, and miR-92 subfamilies). Members in each subfamily share a common seed region (nucleotides 2-7 of mature miRNAs) and are thought to have similar functions. Germline deletion of miR-17\~92 led to perinatal lethality of mutant mice. While ablation of miR-106a\~363 or miR-106b\~25 had no obvious phenotypic consequence, compound mutant embryos lacking both miR-17\~92 and miR-106b\~25 died before embryonic day 15, with defective development of lung, heart, central nervous system, and B lymphocytes^[@R7]^. These genetic studies revealed essential and overlapping functions of miR-17\~92 family miRNAs in many developmental processes.

T cell help is essential for humoral immune responses. A distinct CD4^+^ effector T cell subset, T follicular helper cells (T~FH~), provides this help to B cells^[@R8]^. However, molecular mechanisms underlying T~FH~ differentiation are still largely unknown. Bcl-6 was identified as a critical transcription factor regulating T~FH~ differentiation^[@R9],[@R10],[@R11]^. A recent study reported that Bcl-6 represses the expression of miR-17\~92, which targets the expression of CXCR5, a chemokine receptor essential for CD4^+^ T cell migration to B cell follicles, and suggested that miR-17\~92 functions as a negative regulator of T~FH~ differentiation (the "repression of the repressors" model)^[@R11]^. Here we explore the role of miR-17\~92 family miRNAs in T~FH~ differentiation and germinal center reaction using mice with loss- and gain-of function mutations for those miRNAs. We found that these miRNAs function as critical positive regulators of T~FH~ differentiation by controlling CD4^+^ T cell migration into B cell follicles, and identified Phlpp2 as an important mediator of their function in this process.

RESULTS {#S1}
=======

The miR-17\~92 family regulates T~FH~ differentiation {#S2}
-----------------------------------------------------

We first examined the expression of miR-17\~92 family miRNAs during T~FH~ differentiation. Consistent with a previous report^[@R11]^, their expression in T~FH~ cells was lower than in naive CD4^+^ T cells at day 7 after OVA+Alum+LPS immunization ([Fig. 1a](#F1){ref-type="fig"}). When naive CD4^+^ T cells were activated *in vitro*, the expression of these miRNAs was increased during the first 2 days, peaked around day 2, and decreased afterwards ([Fig. 1b](#F1){ref-type="fig"}). These results suggest that miR-17\~92 family miRNA expression is induced early in T cell activation and then repressed upon completion of the T~FH~ differentiation program. To investigate the role of miR-17\~92 family miRNAs in T~FH~ differentiation, we generated CD4Cre;miR-17\~92^fl/fl^;miR-106a\~363^−/−^;miR-106b\~25^−/−^ mice (termed CD4tKO hereafter) and confirmed loss of expression of these miRNAs in T cells ([Fig. 1c](#F1){ref-type="fig"})^[@R7],[@R12]^. CD4tKO mice exhibited grossly normal lymphocyte development and follicular structures in lymphoid organs (data not shown). We assessed T~FH~ differentiation by immunizing mice with a T cell-dependent antigen, the haptenated protein, 4-hydroxy-3-nitrophenyl-ovalbumin (NP-OVA), precipitated in alum together with lipopolysaccharide (LPS). CD4tKO mice exhibited severely impaired T~FH~ ([Fig. 1d](#F1){ref-type="fig"}) and germinal center B cell (GCB) ([Fig. 1e](#F1){ref-type="fig"}) differentiation, and produced less NP-specific IgM (2\~3 fold less on day 7, data not shown) and IgG1 (15 fold less on day 7 and 2\~3 fold less on days 14 and 21) antibodies than did wild type (WT) mice ([Fig. 1f](#F1){ref-type="fig"}, left panel). CD4tKO mice also showed a defective secondary antibody response (2 fold less than WT at all time points) upon re-immunization, suggesting that the miR-17\~92 family miRNAs regulate not only the initial formation and function of T~FH~ cells, but also the establishment of long-lived protective CD4^+^ T cell dependent B cell responses ([Fig. 1f](#F1){ref-type="fig"}, right panel). Immunohistochemistry analysis revealed a drastic reduction in the number and size of germinal centers in the spleen of immunized CD4tKO mice ([Fig. 1g](#F1){ref-type="fig"} and data not shown). In contrast, miR-17\~92^fl/fl^;miR-106a\~363^−/−^;miR-106b\~25^−/−^ mice (with germline deletion of both miR-106a\~363 and miR-106b\~25 miRNA clusters, termed dKO mice) showed mild reductions in T~FH~ differentiation, GCB formation, and antibody production ([Supplementary Fig. 1a--c](#SD1){ref-type="supplementary-material"}). Similarly, CD4Cre;miR-17\~92^fl/fl^ mice (termed sKO mice) also showed modest reductions in T~FH~ and GCB differentiation upon protein antigen immunization though more pronounced than the dKO mice ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). These results revealed essential and overlapping functions of the miR-17\~92 family miRNA clusters during T~FH~ differentiation.

To examine whether the compromised T~FH~ differentiation in CD4tKO mice reflected a cell-intrinsic miRNA function, we generated WT:CD4tKO mixed bone marrow chimeras and immunized them with NP-OVA+Alum+LPS. Although WT CD4^+^ T cells differentiated into T~FH~ cells, CD4tKO CD4^+^ T cells contributed very little to the T~FH~ cell pool in chimeric mice ([Fig. 1h](#F1){ref-type="fig"}). In contrast, dKO CD4^+^ T cells and B cells underwent relatively normal T~FH~ and GCB cell differentiation in WT:dKO chimeras ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}). These results demonstrate that miR-17\~92 family miRNAs function as CD4^+^ T cell-intrinsic positive regulators of T~FH~ cell differentiation.

CD4tKO mice do not control chronic viral infection {#S3}
--------------------------------------------------

Recent studies suggested that T~FH~ cells play important roles in controlling chronic virus infection^[@R13],[@R14]^. Infection of mice with a high dose of lymphocytic choriomeningitis virus (LCMV) clone-13 (2 x 10^6^ PFU i.v.) resulted in a chronic infection, with virus persisting in multiple tissues for 3--4 months^[@R15]^. Infection of CD4tKO mice with LCMV clone-13 resulted in reduced T~FH~ differentiation ([Fig. 2a, b](#F2){ref-type="fig"}), GCB formation ([Fig. 2c](#F2){ref-type="fig"}), and 3\~6 fold reduction in production of LCMV-specific IgG antibodies ([Fig. 2d](#F2){ref-type="fig"} and [Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). CD4tKO CD4^+^ T cells were severely impaired in their ability to produce IL-21 ([Fig. 2e](#F2){ref-type="fig"}), a cytokine critical for T~FH~ differentiation, GCB formation, and functional CD8^+^ T cell responses during chronic viral infection^[@R16],[@R17],[@R18],[@R19],[@R20],[@R21],[@R22]^. We also investigated CD8^+^ T cell responses during LCMV clone-13 infection. No significant difference in the percentage or total numbers of virus-specific GP33- or GP276-CD8^+^ T cells was observed when comparing CD4tKO to WT mice ([Supplementary Fig. 3b, c](#SD1){ref-type="supplementary-material"}). However, virus specific CD4tKO CD8^+^ T cells expressed elevated levels of the negative immune regulatory molecule PD-1, suggesting a more exhausted state ([Supplementary Fig. 3d](#SD1){ref-type="supplementary-material"})^[@R23]^, and displayed a smaller percentage of IFN-γ^+^TNF-α^+^ double producing cells ([Supplementary Fig. 3e, f](#SD1){ref-type="supplementary-material"}). Finally, we examined whether the impaired development of T~FH~ and GCB cells, compromised antibody and cytokine production, and elevated CD8^+^ T cell exhaustion in CD4tKO mice led to a reduced capacity to control LCMV clone-13 infection. LCMV clone-13 infected CD4tKO mice harbored elevated titers of virus in the serum at days 20, 30 and 50 post-infection compared to WT and dKO mice ([Fig. 2f](#F2){ref-type="fig"} and dKO data not shown). At day 80 post-infection when all WT and dKO mice had completely cleared the virus from the serum, CD4tKO mice maintained greater than 4-logs of virus ([Fig. 2f](#F2){ref-type="fig"} and dKO data not shown). Moreover, CD4tKO mice harbored considerable viral loads in serum and multiple tissues at day 140 post-infection, a time when virus was eliminated in all tissues except kidney in WT and dKO mice ([Fig. 2g](#F2){ref-type="fig"} and dKO data not shown). Taken together, our results demonstrate that CD4tKO mice exhibited defective T~FH~ differentiation during LCMV clone-13 infection and failed to control the virus.

Accumulation of T~FH~ cells in miR-17\~92 transgenic mice {#S4}
---------------------------------------------------------

Next, we examined whether miR-17\~92 over-expression was sufficient to promote the generation of functional T~FH~ cells. We developed transgenic mice (CD4Cre;miR-17\~92 Tg/Tg, termed TG hereafter) in which miR-17\~92 expression was increased by 4\~6 fold in CD4^+^ T cells ([Fig. 3a](#F3){ref-type="fig"})^[@R24]^. Young TG mice had increased numbers of effector/memory CD44^+^CD4^+^ T cells in the spleen ([Supplementary Fig. 4a, b](#SD1){ref-type="supplementary-material"}). These young TG mice exhibited spontaneous T~FH~ differentiation and GCB formation, whereas the percentages of other T helper (T~H~) cell subsets among CD44^+^CD4^+^ T cells were not affected ([Fig. 3b](#F3){ref-type="fig"} and [Supplementary Fig. 4c, d](#SD1){ref-type="supplementary-material"}). These spontaneously generated T~FH~-like cells expressed Bcl-6, the signature transcription factor for T~FH~ cells ([Fig. 3b](#F3){ref-type="fig"}). T~FH~ cell expansion has been observed in a subset of lupus patients and in *sanroque* mice, a mutant mouse strain that spontaneously develops systemic autoimmunity, and was shown to play a causative role in the latter^[@R25],[@R26],[@R27]^. We monitored a cohort of 24 WT and 35 TG mice for more than 20 months for disease development. All TG mice died prematurely, with an average life span of 40 weeks ([Fig. 3c](#F3){ref-type="fig"}). Examination of sick TG mice revealed that they developed splenomegaly and lymphadenopathy ([Supplementary Fig. 4e](#SD1){ref-type="supplementary-material"}), accumulated T~FH~ and GCB cells ([Fig. 3d](#F3){ref-type="fig"}) in lymphoid organs, produced autoantibodies to double stranded DNA ([Fig. 3e](#F3){ref-type="fig"}), and exhibited lymphocyte infiltration into non-lymphoid organs ([Supplementary Fig. 4f](#SD1){ref-type="supplementary-material"}). Therefore, T cell-specific over-expression of miR-17\~92 caused spontaneous T~FH~ differentiation and fatal immunopathology.

To demonstrate that enhanced T~FH~ differentiation in TG mice was intrinsic to CD4^+^ T cells, we generated WT:TG mixed bone marrow chimeras. Three months after reconstitution, a significantly increased proportion of TG CD4^+^ T cells acquired T~FH~ phenotypes, whereas most WT CD4^+^ T cells remained undifferentiated ([Fig. 3f](#F3){ref-type="fig"}). In addition, retroviral over-expression of miR-17\~92 in naive WT CD4^+^ T cells led to a two-fold increase in T~FH~ differentiation *in vitro*, whereas T~H~1 differentiation was not affected ([Fig. 3g](#F3){ref-type="fig"}). Retroviral miR-17\~92 over-expression promoted T~FH~ differentiation without increasing Bcl-6 protein in the differentiated CXCR5^+^PD1^hi^ T~FH~ cells ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). This data suggests that the Bcl-6 protein level is not directly controlled by miR-17\~92 family miRNAs. Taken together, these results show that miR-17\~92 over-expression is sufficient to drive T~FH~ differentiation and this effect is CD4^+^ T cell intrinsic.

CD4tKO CD4+ T cells do not migrate into B cell follicles {#S5}
--------------------------------------------------------

We introduced the OT-II T cell receptor transgene to CD4tKO mice to study the effect of the miR-17\~92 family miRNAs on antigen-specific CD4^+^ T cells during T~FH~ differentiation^[@R28]^. We adoptively transferred carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled naive Ly5b WT or CD4tKO OT-II CD4^+^ T cells into B6.Ly5a recipients, immunized the recipients with OVA+alum, and analyzed transferred OT-II CD4^+^ T cells at various time points. In agreement with our previous results, CD4tKO OT-II CD4^+^ T cells failed to differentiate into CXCR5^hi^Bcl-6^+^ T~FH~ cells effectively ([Fig. 4a](#F4){ref-type="fig"}, day 6.5). We examined cell proliferation, activation marker up-regulation, and the expression of other molecules functionally important for T~FH~ differentiation on days 2.5, 3.5, and 6.5 post immunization. The proliferation of CD4tKO OT-II CD4^+^ T cells was similar to their WT counterparts ([Fig. 4b](#F4){ref-type="fig"}). The up-regulation of activation markers (CD44, ICOS, PD-1, and CD40L) was slightly reduced on days 2.5 and 3.5, but reached the WT levels by day 6.5 ([Fig. 4c](#F4){ref-type="fig"}). Consistent with a previous report^[@R29]^, Bcl-6 expression was up-regulated in almost all WT OT-II CD4^+^ T cells on day 2.5, with a fraction of them expressing CXCR5 (day 2.5, [Fig. 4a, c](#F4){ref-type="fig"}). Subsequently, Bcl-6 expression was down-regulated in a large majority of WT OT-II CD4^+^ T cells, with about 30% of them remaining positive for both Bcl-6 and CXCR5, which presumably differentiated into T~FH~ cells (days 3.5 and 6.5, [Fig. 4a, c](#F4){ref-type="fig"}). Importantly, the up-regulation of Bcl-6 in CD4tKO OT-II CD4^+^ T cells was severely impaired throughout the whole period of observation, with a much smaller fraction of those cells becoming CXCR5^hi^ Bcl-6^+^ T~FH~ cells ([Fig. 4a, c](#F4){ref-type="fig"}). On day 6.5, the expression levels of Bcl-6 and CXCR5 in CD4tKO OT-II CD4^+^ cells remained lower than in WT OT-II CD4^+^ cells ([Fig. 4c](#F4){ref-type="fig"}). We also examined the location of CD4tKO OT-II CD4^+^ cells in draining lymph nodes during immune responses. On day 2.5 after immunization, both WT and CD4tKO OT-II CD4^+^ cells had proliferated and resided in the T cell zone ([Fig. 4b, d](#F4){ref-type="fig"}, day 2.5). There was almost a complete lack of CD4tKO OT-II CD4^+^ T cells in B cell follicles and germinal centers on days 3.5 and 6.5, when WT OT-II CD4^+^ T cells have migrated into these areas *en masse* ([Fig. 4d](#F4){ref-type="fig"}). These results indicate that CD4tKO OT-II CD4^+^ T cells lose the ability to migrate to B cell follicles and germinal centers.

The miR-17\~92 family regulates T~FH~ cell generation after activation {#S6}
----------------------------------------------------------------------

The delayed up-regulation of activation markers (CD44, ICOS, PD-1, and CD40L) and the compromised induction of Bcl-6 and CXCR5 on day 2.5 of the immune response show that CD4tKO OT-II CD4^+^ T cells exhibit early activation defects ([Fig. 4a, c](#F4){ref-type="fig"}), which may indirectly compromise T~FH~ differentiation. To examine this possibility, we generated OX40Cre;miR-17\~92^fl/fl^;miR-106a\~363^−/−^;miR-106b\~25^−/−^ mice (termed OX40tKO hereafter), in which OX40Cre is induced upon T cell activation and deletes the miR-17\~92 gene specifically in activated CD4^+^ T cells. Northern Blot analysis of *in vitro* activated CD4^+^ T cells showed that the depletion of miR-17\~92 started on day 2 and completed on day 3--5 ([Fig. 5a](#F5){ref-type="fig"}). OX40tKO mice exhibited a clear T~FH~ differentiation defect upon NP-OVA+LPS+Alum immunization ([Fig. 5b, c](#F5){ref-type="fig"}), although the defect was milder than that in CD4tKO mice, probably reflecting a modest role of the miR-17\~92 family miRNAs during the early phase of T cell activation. These results clearly demonstrate that the miR-17\~92 family miRNAs play an essential role in T~FH~ differentiation beyond the initial phase of T cell activation.

We further investigated whether this role of the miR-17\~92 family miRNAs is specific for T~FH~ differentiation. We infected OX40tKO mice with LCMV Armstrong strain, which causes acute infection and promotes the differentiation of CD4^+^ T cells into both T~FH~ and T~H~1 subsets. On day 8 post infection, OX40tKO mice exhibited severely compromised T~FH~ differentiation, whereas T~H~1 differentiation was only slightly reduced ([Fig. 5d, e](#F5){ref-type="fig"}). Taken together, our results show that the miR-17\~92 family miRNAs specifically regulate T~FH~ differentiation beyond the initial phase of T cell activation. As follicular localization following activation is a critical step of the T~FH~ differentiation program, and the deficiency of miR-17\~92 family miRNAs severely impaired this process ([Fig. 4d](#F4){ref-type="fig"}), these miRNAs may control T~FH~ differentiation by specifically regulating molecular events underlying the migration process.

Phosphatase PTEN partially contributes to miR-17\~92 function {#S7}
-------------------------------------------------------------

A previous study has shown that ICOS directly controls CD4^+^ T cell migration from the T-B border into B cell follicles^[@R30]^. The PI3K pathway is the only known signaling pathway downstream of ICOS that is required for T~FH~ and germinal center development^[@R31],[@R32]^. Given the fact that Pten, a direct target gene of the miR-17\~92 family miRNAs^[@R24]^, antagonizes PI3K function, we first tested whether these miRNAs could promote CD4^+^ T cell migration into B cell follicles through augmenting ICOS-PI3K signaling via Pten suppression. Indeed, Pten protein was increased in naive CD4tKO CD4^+^ T cells, and PI3K downstream signaling was severely impaired upon anti-CD3+CD28 stimulation *in vitro* ([Fig. 6a, b](#F6){ref-type="fig"}). To determine the contribution of increased Pten protein on the T~FH~ defect in CD4tKO mice, we generated CD4Cre;miR-17\~92^fl/fl^;miR-106a\~363^−/−^;miR-106b\~25^−/−^; Pten^fl/+^ mice (termed CD4tKO;Pten^fl/+^ mice). However, restoration of Pten protein by deleting one copy of the Pten gene in CD4tKO CD4^+^ T cells only partially (\~25%) rescued the T~FH~ differentiation defect in CD4tKO mice ([Fig. 6c--e](#F6){ref-type="fig"}). In addition, the rescue of antibody response was marginal ([Fig. 6f](#F6){ref-type="fig"}). We also generated and analyzed CD4Cre;Pten^fl/+^ mice to assess the contribution of Pten to the phenotypes of TG mice. While young CD4Cre;Pten^fl/+^ mice did not exhibit any significant alterations in the number and percentage of effector/memory T cells (data not shown), 9 month old CD4Cre;Pten^fl/+^ mice showed increased numbers of CD4^+^ T cells and CD44^+^ effector/memory T cells ([Supplementary Fig. 6a, b](#SD1){ref-type="supplementary-material"}), accompanied by spontaneous development of T~FH~ and GCB cells that is reminiscent of young TG mice ([Supplementary Fig. 6c, d](#SD1){ref-type="supplementary-material"}). These results suggest that Pten is indeed an important contributor to miR-17\~92 family miRNA-mediated regulation of T~FH~ differentiation, but additional, and possibly more important, target genes must also be involved in this process.

Phlpp2 mediates miR-17\~92 control of T~FH~ differentiation {#S8}
-----------------------------------------------------------

It is thought that miRNAs target multiple components of functionally related pathways to achieve significant impact on the biological processes they regulate^[@R5]^. We examined additional components of the PI3K signaling pathway to identify potential miR-17\~92 family miRNA target genes. The phosphatase Phlpp2 inactivates the PI3K downstream effector Akt, and is a miR-17\~92 target in human mantle cell lymphoma cell lines^[@R33]^. The murine Phlpp2 gene contains one miR-17 and two miR-92 binding sites in its 3′ UTR and those sites were responsive to miR-17\~92-mediated suppression in reporter assays ([Fig. 7a, b](#F7){ref-type="fig"}). Phlpp2 protein was low in naive CD4^+^ T cells, strongly induced upon T cell activation, peaked around day 2, and was reduced afterwards ([Fig. 7c](#F7){ref-type="fig"}). Consistent with its role as a miR-17\~92 family miRNA target gene, activation-induced Phlpp2 protein levels were clearly increased in CD4tKO CD4^+^ T cells ([Fig. 7c](#F7){ref-type="fig"}). We hypothesized that exaggerated activation-induced Phlpp2 protein expression beyond day 2 impaired ICOS-PI3K signaling and compromised T cell migration into B cell follicles. Indeed, adoptively transferred CD4tKO OT-II CD4^+^ T cells exhibited much reduced PI3K pathway activity as measured by phospho-S6 (pS6) on day 3.5 after immunization ([Fig. 7d](#F7){ref-type="fig"}), around the time when T cells began to migrate into B cell follicles. Examination of ICOS-PI3K signaling *in vitro* showed that it was compromised in activated CD4tKO CD4^+^ T cells and this was not due to reduced ICOS expression ([Fig. 7e](#F7){ref-type="fig"} and [Supplementary Fig 7a, b](#SD1){ref-type="supplementary-material"}). As Phlpp2 knockout mice have not been reported, we used retrovirus-encoded shRNAs to knock down the Phlpp2 protein in CD4tKO CD4^+^ T cells to that found in WT CD4^+^ T cells. This restored ICOS-PI3K signaling in previously activated CD4tKO CD4^+^ T cells ([Supplementary Fig. 7c, d](#SD1){ref-type="supplementary-material"}). We then adoptively transferred control or Phlpp2 shRNA-encoding retrovirus infected CD4tKO OT-II CD4^+^ T cells into WT recipients, and analyzed their differentiation into T~FH~ cells upon protein antigen immunization. Phlpp2 knockdown in CD4tKO OT-II CD4^+^ T cells substantially restored their ability to differentiate into T~FH~ cells *in vivo* and partially restored their migration into B cell follicles ([Fig. 7f, g](#F7){ref-type="fig"}). Conversely, Phlpp2 overexpression in WT CD4^+^ T cells impaired ICOS-PI3K signaling and their ability to migrate into B cell follicles, but did not significantly change their differentiation into CXCR5^hi^Bcl-6^+^ cells ([Fig. 7h](#F7){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). These results are consistent with the recent finding that ICOS signaling controls follicular recruitment of CD4^+^ T cells independent of CXCR5 and Bcl-6 expression ^[@R30]^. Taken together, our data demonstrate that Phlpp2 is an important regulator of CD4^+^ T cell migration into B cell follicles, and that miR-17\~92 family miRNAs control T~FH~ differentiation in part by limiting T cell activation-induced Phlpp2 protein concentration to a proper range that allows productive ICOS-PI3K signaling to drive T cell migration into B cell follicles ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}).

DISCUSSION {#S9}
==========

Based on the results presented in this study, we propose the following model of miR-17\~92 family-mediated regulation of T~FH~ differentiation. The expression of both miR-17\~92 family miRNAs and their target gene Phlpp2 are low in naive CD4^+^ T cells. They are induced upon T cell activation, peak around day 2, and are downregulated afterwards. Downregulation of Phlpp2 after day 2 is critical for ICOS-PI3K signaling, which drives T cell migration into B cell follicles^[@R30]^, a defining feature of the T~FH~ differentiation program. The upregulation of miR-17\~92 family miRNAs serves to limit the activation-induced Phlpp2 protein to a proper range, as exaggerated and prolonged Phlpp2 protein expression would impair ICOS-PI3K signaling. Indeed, complete deletion of the miR-17\~92 family miRNAs in T cells results in dysregulated Phlpp2 protein expression, compromised ICOS-PI3K signaling, reduced migration into B cell follicles, and impaired T~FH~ differentiation. As T cell migration into B cell follicles is not required for the differentiation of other CD4^+^ effector T cell subsets, this model explains why T~FH~ differentiation is severely compromised in OX40tKO mice during LCMV Armstrong infection, whereas T~H~1 differentiation remains relatively normal in those animals.

The complete block of CD4tKO CD4^+^ T cell migration into B cell follicles is almost identical to that caused by ICOS deficiency^[@R30]^. However, CD4tKO CD4^+^ T cells can still differentiate into CXCR5^hi^Bcl-6^+^ cells, though at a much reduced efficiency. This is in sharp contrast to ICOS-deficient CD4^+^ T cells, whose differentiation into CXCR5^hi^Bcl-6^+^ cells is completely abolished^[@R34]^. The differential regulation of follicular recruitment and differentiation into CXCR5^hi^Bcl-6^+^ cells by miR-17\~92 family miRNAs and ICOS suggests that these two facets of the T~FH~ differentiation program are controlled by distinct, and yet partially overlapping, molecular pathways. This idea is further supported by the consequences of Phlpp2 overexpression in WT CD4^+^ T cells, which severely impaired their follicular recruitment but not differentiation into CXCR5^hi^Bcl-6^+^ cells. Elucidation of molecular pathways underlying these two facets holds the key to understanding the T~FH~ differentiation program.

It is important to emphasize that Phlpp2 is not the only functionally important target through which miR-17\~92 family miRNAs regulate T~FH~ differentiation, as Phlpp2 knockdown only partially restored follicular recruitment and T~FH~ differentiation of CD4tKO OT-II CD4^+^ T cells. Pten is clearly another important mediator of miR-17\~92 family function, as deleting one copy of the Pten gene partially restored T~FH~ and GCB differentiation in CD4tKO mice. Other functionally important targets may exist and mediate miR-17\~92 family control of various aspects of the T~FH~ differentiation program. Future investigation is warranted to identify additional targets and evaluate their contribution to the functions of the miR-17\~92 family.

Previous studies showed that miR-17\~92 regulates CD4^+^ T cell activation and proliferation *in vitro*^[@R24],[@R35]^. By examining CD4tKO OT-II CD4^+^ T cells during immune responses against a protein antigen, we showed in this study that the deficiency of miR-17\~92 family miRNAs had negligible effect on CD4^+^ T cell proliferation and caused a modest delay in their activation *in vivo*. The delayed activation is not the direct cause of T~FH~ differentiation defect in CD4tKO mice, as deleting miR-17\~92 family miRNAs beyond the initial activation phase by OX40Cre caused a similar T~FH~ differentiation defect. Therefore, the miR-17\~92 family miRNAs play a general role in the activation of CD4^+^ T cells and a specific role in their differentiation into T~FH~ cells.

In summary, our loss- and gain-of function studies demonstrate that miR-17\~92 family miRNAs are critical regulators of T~FH~ differentiation and that Phlpp2, the recently discovered Akt phosphatase, is an important mediator of the functions of these miRNAs. Given the crucial roles of T~FH~ cells in germinal center reaction and antibody responses, manipulating miR-17\~92 family miRNAs or their target genes and pathways *in vivo* may facilitate the design of better vaccines and the development of therapeutic regimens treating autoimmune diseases.

ONLINE METHODS {#S10}
==============

Mice {#S11}
----

The generation of miR-17\~92^fl/fl^ (Jax stock 008458), miR-106a\~363^−/−^ (Jax stock 008461), miR-106b\~25^−/−^ (Jax stock 008460), miR-17\~92 Tg (Jax stock 008517), CD4-Cre (Jax stock 017336), OT-II (Jax stock 004194), and *Pten*^fl/fl^ (Jax stock 006440) mice was previously described^[@R7],[@R12],[@R24],[@R28],[@R36]^. All mice were bred and housed under SPF conditions. Disease development was monitored by frequent visual examination and histopathological analyses. All mice were used in accordance with guidelines from the Institutional Animal Care and Use Committee of The Scripps Research Institute.

Mixed bone marrow chimera {#S12}
-------------------------

Ly5a B6 or *Rag1*^−/−^ mice were irradiated with two rounds of 600 cGy with a 3 h interval. Bone marrow cells from WT B6 (Ly5a or Ly5a/b) and tKO or TG (Ly5b) mice were subjected to red blood cell lysis and T cell depletion by magnetic separation. 1:1 mixed 5x10^6^ bone marrow cells were transferred via tail vein injection. Eight weeks later, the mice were immunized with NP-OVA+Alum+LPS intraperitoneally. Spontaneous generation of T~FH~ cells in WT:TG chimeras was analyzed at 3 months after reconstitution.

Antibodies and reagents {#S13}
-----------------------

Anti-CD4 (GK1.5), CD25 (PC61), CD44 (IM7), CD69 (H1.2F3), CD45.1 (A20), CD45.2 (104), CD40L (MR1), PD-1 (RMP1-30), ICOS (15F9), ICOS (C398.4A, agonist for T~FH~ cell differentiation) and biotin anti-rat IgG2a (MRG2a-83) were purchased from Biolegend. Anti-CXCR5 (2G8), PE-conjugated CXCR5 (2G8), -Bcl-6 (K112-91), -CD95 (Jo2), IgD(11-26c.2a), APC-conjugated CD3 (2C11) and Alexa Fluor® 647-conjugated GL-7 (GL7) were from BD Pharmingen. Recombinant human IL-2, mouse IL-6, and mouse IL-21 were purchased from Peprotec. Anti-Pten (138G6), phospho-Akt (Ser473; D9E), phospho-Akt (Thr308; 244F9) and phospho-S6 (2F9) were from Cell Signaling. Goat anti-hamster IgG antibody was purchased from Pierce. Anti-Phlpp2 antibody (A300-661A) was purchased from Bethyl Laboratories.

Cell isolation and *in vitro* activation {#S14}
----------------------------------------

Total CD4^+^ T cells were isolated from pooled single cell suspensions of spleen and lymph nodes by using mouse CD4^+^ T cell isolation kit II (Miltenyi Biotech). Naive CD4^+^ T cells (CD4^+^CD25^−^CD44^−^CD69^−^) were purified from isolated CD4^+^ T cells by MACS depletion of CD25^+^, CD44^+^, and CD69^+^ cells (\>97% purity). For Northern blot, naive CD4^+^ T cells were activated with plate coated anti-CD3 (5 μg/ml) in the presence of anti-CD28 (2 μg/ml) for indicated amounts of time. For T~FH~ isolation, WT B6 mice were immunized with OVA/Alum/LPS and CD4^+^ T cells were isolated from spleen at day 7 after immunization. Isolated CD4^+^ T cells were stained and FACS-sorted for naive CD4^+^ T cells (CD4^+^CD62L^+^CXCR5^−^PD1^−^CD44^−^), pre-T~FH~ (CD4^+^CXCR5^hi^PD1^low^), and T~FH~ (CD4^+^CXCR5^hi^PD1^hi^).

Immunization {#S15}
------------

Antigens for immunization were prepared by mixing NP~18~-OVA (Biosearch Technologies), OVA (albumin from chicken egg white, grade II, Sigma), or NP~36~-CGG (Biosearch Technologies) dissolved in PBS and 10% KAl(SO4)~2~ at 1:1 ratio, in the presence or absence of LPS (*Escherichia coli* 055:B5,Sigma), and adjusting pH to 7 to form precipitate. 100 μg NP-OVA and 10 μg LPS precipitated in alum was injected intraperitoneally (i.p.) for flow cytometry analysis of T~FH~ and GCB formation. 5 μg NP-CGG precipitated in alum was injected i.p. for NP-specific antibody responses. 25 μg OVA precipitated in alum was injected subcutaneously (s.c.) at flank areas for OT-II CD4^+^ T cell adoptive transfer experiments.

LCMV infection {#S16}
--------------

The clone-13 strain of LCMV was propagated on BHK cells and supernatants were clarified by load speed centrifugation, directly titered, and used for infection. For determination and quantification of viremia, blood was drawn from the retro-orbital sinus under isoflurane anesthesia. Serum was isolated by centrifugation to remove red and white blood cells. 10 μl serum was used to perform 10-fold serial dilutions for plaque assays on VERO cells^[@R37]^. Lung, liver, spleen and kidney were harvested from euthanized mice and frozen at −80 °C. At the time of assay, tissues were thawed, weighed and homogenized in 1 ml media, clarified by centrifugation and 10 μL of the supernatant was used to perform 10-fold serial dilutions for plaque assays. For LCMV Armstrong, mice were infected with the LCMV Armstrong 53b strain at a dose of 2 x 10^6^ PFU intravenously.

Flow cytometry analysis {#S17}
-----------------------

Single cell suspensions were prepared from spleen or draining lymph nodes. Antibodies for cell surface markers were added and incubated for 30 min at 4 °C. For most CXCR5 staining, single cells were stained with purified anti-mouse CXCR5, followed by anti-rat IgG2a and Streptavidin-PE. PE conjugated anti-mouse CXCR5 antibody was used for staining *in vitro* differentiated T~FH~ cells. For CD40L staining, cells were stained for cell surface markers, fixed with 1% PFA for 1 h at 4 °C, permeabilized with FACS buffer containing 0.1% saponin (Sigma), and incubated with PE-conjugated anti-CD40L for 30 min at 4 °C. Foxp3 staining kit (eBioscience) was used to stain Bcl-6 following manufacturer's instructions. Briefly, surface marker stained cells were fixed with Fixation/Permeabilization buffer for 1 h at 4 °C, washed with 1x Permeabilization buffer, and incubated with anti-Bcl-6 at room temperature for 1 h in 1x Permeabilization buffer. Bcl-6 staining of *in vitro* differentiated T~FH~ cells was performed with FACS-sorted GFP^+^ cells. All flow cytometry data was acquired on LSRII flow cytometers (Becton Dickinson) and analyzed using the FlowJo software (Treestar, Inc.).

Adoptive transfer {#S18}
-----------------

Naive WT or tKO OT-II cells (1x10^6^) were adoptive transfer experiments into B6.Ly5a mice via tail vein injection and immunized one day after transfer. CD4tKO OT-II cells with Phlpp2 knockdown (3x10^6^) or WT OT-II cells with Phlpp2 overexpression (2X10^5^) were transferred into B6.Ly5a mice, which were immunized with 25 μg Ova/Alum s.c. one day after transfer.

Immunostaining {#S19}
--------------

Freshly dissected tissues were instantly frozen in OCT. Sections of 8\~15 μm were cut with a Leica Cryostat, mounted on Superfrost Plus glass slides, fixed in cold acetone for 10 minutes, air dried, and stained for IgD to label the follicular mantle, CD3 to identify T cells, Bcl-6 to identify the germinal center area, or Ly5b to detect adoptively transferred OT-II CD4^+^ T cells. For some experiments, GFP expressed by the retroviral vector was used to identify infected cells. Images were acquired with an Olympus FV1000 microscopy and processed with Bitplane Imaris. Tiling of images to cover large tissue areas was done using Adobe Photoshop.

Intracellular cytokine staining {#S20}
-------------------------------

Splenocytes were stimulated for 5 h with 2 μg/ml MHC class I restricted LCMV-GP~33--41~ or LCMV-GP~276--286~ peptides (\>99% pure; American Peptide and The Scripps Research Institute, Center for Protein Science, La Jolla, CA) in the presence of 4 μg/ml brefeldin A (Sigma). Cells were fixed, permeabilized with 2% saponin, and stained intracellularly with antibodies to IFN-γ (XMG1.2), TNF (MP6-XT22) and IL-2 APC (JES6-5H4). Tetramer positive cells were detected by staining with SA-APC conjugated GP33 (GP~33--41~) or GP276 (GP~276--286~) tetramers for 1 h at 4 °C. Absolute cell numbers were determined by multiplying the frequency of specific cell populations by the total number of viable cells. For [Fig. 2e](#F2){ref-type="fig"}, [Fig. 3g](#F3){ref-type="fig"}, and [supplementary Fig 4c--d](#SD1){ref-type="supplementary-material"}, cells were stimulated for 4h with PMA (50ng/ml, Sigma) and ionomycin (1μg/ml, Sigma) in the presence of monensin (Biolegend). The cells were fixed and permeabilized as described above and stained with antibodies for IFN-γ (XMG1.2) (T~H~1), IL-4 (11B11) (T~H~2) or IL-17A (TC11-18H10.1) (T~H~17). For IL-21 intracellular staining, recombinant mIL-21R-Fc chimera protein (R&D Systems) and PE-conjugated goat anti--human Fcγ antibody (Jackson ImmunoResearch Laboratories) were used as previously described^[@R38]^.

*In vitro* T~FH~ cell differentiation {#S21}
-------------------------------------

To obtain recombinant virus, 10 μg RV-miR-17\~92 or control RV-GFP vector was transfected into phoenix-eco cells, a retroviral packaging cell line derived from 293T cells. The supernatants were collected 48 h after transfection and filtered through a 0.45 μm membrane. Naive CD4^+^ T cells were activated with anti-CD3 and anti-CD28 for 24 h, infected with retroviral supernatants in the presence of polybrene (6 μg/ml) by spinoculation and further activated with anti-CD3 and anti-CD28, in the presence of anti-TGFβ (antagonist; 5μg/ml), anti-ICOS (agonist; 5μg/ml), recombinant human IL-2 (rhIL-2; 100 U/ml), recombinant mouse IL-6 (rmIL-6; 10ng/ml), and recombinant mouse IL-21 (rmIL-21; 10ng/ml) for 3--5 days^[@R39]^.

ELISA {#S22}
-----

Microtiter plates were coated with salmon sperm DNA (5 μg/ml, Invitrogen) in Reacti-Bind DNA Coating Solution (Thermo Scientific) for measuring anti-dsDNA autoantibody, with NP-BSA (10 μg/ml, Biosearch Technologies) in PBS for measuring NP-specific antibody, LCMV clone-13 virus particles for measuring anti-LCMV antibody. The plates were blocked with PBSA (0.5% BSA in PBS). Serum samples were serially diluted in PBSA and incubated in blocked plates overnight at 4°C. The plates were incubated with Biotin-conjugated anti-IgM, IgG1, IgG2a, IgG2b, or pan-IgG (Southern Biotech) for 2 hours, streptavidin-alkaline phosphatase (Roche) for 1 hour, alkaline phosphatase substrate solution containing 4-nitro-phenyl phosphate (Sigma) for color development, and measured on a VERSAmax microplate reader (Molecular Devices).

Northern blot {#S23}
-------------

Total RNA was extracted from CD4^+^ T cells isolated from WT, tKO, and TG mice at greater than 95% purity using TRIzol® Reagent (Life Technologies) following manufacturer's instructions. 8 μg total RNA was used to detect miRNAs. DNA oligonucleotides antisense to mature miRNAs were used as probes. U6 snRNA was used as internal control for normalization. Northern blot results were acquired on a STORM 860 phosphorimager and analyzed using the ImageQuant software.

Luciferase reporter assay {#S24}
-------------------------

WT or mutated Phlpp2 3′UTR R1 and R2 regions containing miR-17 or miR-92 binding sites were cloned into the psiCHECK-2 dual reporter assay vector. *Renilla* luciferase activity was measured in HeLa cells in the presence or absence of miR-17\~92 overexpression and normalized with firefly luciferase activity (Rluc/Fluc). The Rluc/Fluc ratios were arbitrarily set at 100 for HeLa cells without miR-17\~92 overexpression. Primers for cloning R1 and R2 regions are:

1.  R1for: 5′-TATTACTCGAGCTGACATGGTGACATGGTTC-3′;

2.  R1rev: 5′-TATTAGCGGCCGCGCAGTGATAGAGCATCCTCC-3′;

3.  R2for: 5′-TATTACTCGAGCTGAAGAAAGAGCACTCGGC-3′;

4.  R2rev: 5′-TATTAGCGGCCGCTGCAACATGCTCTGGCTC-3′

Retroviral infection {#S25}
--------------------

Annealed *Phlpp2* shRNA oligonucleotides (5′-GATCGCAATGACTTGACAGAAA TCCTCTAAAGGAGGATTTCTGTCAAGTCATTGC-3′) or PHLPP2 were inserted into Thy1.1-expressing RV vector. S-Eco packaging cells were transfected by using Fu-GENE HD (Promega) and retroviral supernatants were collected 48 hours after transfection. Naive CD4^+^ T cells were stimulated with 5 μg/ml anti-CD3 and 2 μg/ml anti-CD28 for 1 day and then transduced with retroviral supernatants in the presence of 6 μg/ml polybrene (SIGMA) by spin infection for 1 h at 1800 rpm.

ICOS stimulation {#S26}
----------------

Naive CD4^+^ T cells were stimulated with 5 μg/ml anti-CD3 and 2 μg/ml anti-CD28 for 3 days and rested for 3 h. One million cells were stimulated with soluble anti-ICOS (5 μg/ml) and goat anti-hamster antibodies (10 μg/ml) in 100 μl medium for indicated amounts of time.

Immunoblotting {#S27}
--------------

Freshly isolated or stimulated naive CD4^+^ T cells were washed with PBS twice and lysed in cell lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA) supplemented with Halt Protease & Phosphatase Inhibitor Cocktail (Thermo Scientific). Primary antibodies were diluted in 5% w/v BSA in 1X TBS buffer (10 mM Tris-HCl, pH8.0, 150 mM NaCl) and incubation was done at 4°C overnight.

Histological analysis {#S28}
---------------------

Tissues from sick TG and age matched control mice were fixed in 4% formalin solution. Hematoxylin-eosin stained slides were prepared by the TSRI Histology Core following standard procedures.

Statistical analysis {#S29}
--------------------

A total of 4\~10 mice per group were used in each animal experiments. This number routinely provides the statistical power to define meaningful differences between groups when they exist. When differences between groups approach statistical significance (p=0.1\~0.05), we used more mice for a more rigorous test of statistical significance. Student unpaired *t* test was used for statistical analysis. *P* values \<0.05 was considered significant and all graphs were presented means± s.e.m.
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![miR-17\~92 family miRNAs regulate T~FH~ differentiation during protein antigen immunization. (**a--c**) Expression of miR-17\~92 family miRNAs in sorted naive CD4^+^ T and CXCR5^hi^PD1^hi^ T~FH~ cells (**a**), naive and activated WT CD4^+^ T cells (**b**), and CD4tKO CD4^+^ T cells (**c**, n=3) was determined by Northern blot. Numbers indicate miRNA/U6 ratios normalized to naive CD4^+^ T cells. (**d,e**) CXCR5^hi^PD1^hi^ T~FH~ (**d**) and FAS^+^GL-7^+^ GCB cells (**e**) were analyzed at days 7 and 14 after intraperitoneal (i.p) immunization with NP-OVA+Alum+LPS (n=6 per group). (**f**) WT and CD4tKO mice were immunized with 10μg NP-CGG+Alum (i.p.), followed by secondary immunization with 5μg NP-CGG (i.p.) on day 111 after primary immunization. Serum was collected at indicated time points. NP-specific IgG1 antibody concentration was determined by ELISA (n=8 per group). (**g**) Immunohistochemistry analysis of germinal centers. Spleens of NP-OVA+Alum+LPS immunized mice were examined at day 7 after immunization (i.p). Scale bar, 50 μm. (**h)** Lethally irradiated B6 Ly5a mice were reconstituted with B6 Ly5a/b and tKO Ly5b bone marrow cells (1:1), immunized with NP-OVA+Alum+LPS (i.p) at eight weeks after reconstitution, and T~FH~ differentiation in the spleen was analyzed at days 7 or 14 after immunization. Data are representative of two (**a**) and three (**b**) independent experiments. All graphs are shown as means± s.e.m. \*, *p* \< 0.05; \*\*, *p* \< 0.01.](nihms484743f1){#F1}

![miR-17\~92 family miRNAs regulate T~FH~ differentiation during chronic viral infection. (**a--e**) CXCR5^hi^PD1^hi^ (**a**) and CXCR5^hi^Bcl-6^+^ (**b**) T~FH~ cells, FAS^+^GL-7^+^ GCB cells (**c**), and IL-21 producing cells (**e**) were analyzed in spleen of mice at day 30 after LCMV clone-13 infection (**a--c**, n=8 per group; **e**, n=4\~5 per group). (**d**) anti-LCMV IgG concentration in serum was determined by ELISA. (**f,g**) LCMV clone-13 infected mice were bled at the indicated times (**f**), euthanized at day 140 post-infection (**g**), and viral titers in serum and tissues were measured by plaque assay (representatives of two independent experiments). All graphs are shown as means± s.e.m. \*, *p* \< 0.05; \*\*, *p* \< 0.01; \*\*\*, *p* \< 0.001.](nihms484743f2){#F2}

![Spontaneous accumulation of T~FH~ cells in T cell-specific miR-17\~92 transgenic mice. (**a**) Expression levels of miR-17\~92 family miRNAs in TG CD4^+^ T cells (n=3) were determined by Northern blot. Numbers indicate miRNA/U6 ratios normalized to naive WT CD4^+^ T cells. (**b**) CXCR5^hi^PD1^hi^ T~FH~ (upper), CXCR5^hi^ Bcl-6^+^ T~FH~ (middle) and FAS^+^GL-7^+^ GCB cells (lower) were analyzed in the spleen of 6\~8 week old non-immunized mice (n=5\~7 per group). (**c**) Survival curves of TG (n=35) and WT mice (n=24). (**d**) T~FH~ (upper) and GCB (lower) cells in splenocytes of 8 month old WT and TG mice. (**e**) Serum anti-dsDNA antibody concentration in TG and WT mice at 6--8 months of age was determined by ELISA. The serum titers of aged MRL-*lpr/lpr* mice were arbitrary set at 1x10^3^. (**f**) Lethally irradiated B6.*Rag1^−/−^* mice were reconstituted with B6 (Ly5a) and WT or TG (Ly5b) mixed bone marrow cells (1:1), and spontaneous T~FH~ cell differentiation in the spleen was analyzed at 3 months after reconstitution (n=3 per group). (**g**) WT naive CD4^+^ T cells were transduced with RV-miR-17\~92 or RV-control and activated *in vitro* in the presence of anti-IL-4, anti-IFNγ, IL-6 and IL-21 for T~FH~ (upper panel) or anti-IL-4 and IL-12 for T~H~1 (lower panel) differentiation. GFP^+^ cells were gated and plotted (representatives of three independent experiments). Bcl-6 expression in *in vitro* differentiated T~FH~ cells is presented in [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}. All graphs are shown as means± s.e.m. \*, *p* \< 0.05; \*\*, *p* \< 0.01.](nihms484743f3){#F3}

![The effect of miR-17\~92 family miRNAs on antigen-specific CD4^+^ T cells during *in vivo* T~FH~ differentiation. (**a--d**) CFSE labeled or unlabeled Ly5b^+^ WT or CD4tKO naive OT-II CD4^+^ T cells were transferred into B6.Ly5a mice, which were subsequently immunized with OVA+Alum subcutaneously. T~FH~ differentiation (**a**), cell proliferation (**b**), expression of activation markers (**c**), and localization (**d**) of adoptively transferred Ly5b^+^ OT-II CD4^+^ T cells in inguinal lymph nodes were analyzed by flow cytometry (**a--c**) or immunohistochemistry (**d**) at indicated times (3--5 mice per group). IgD^+^ area, IgD^−^ area, and \* indicate B cell follicle, T cell zone, and germinal center, respectively. Scale bar, 100 μm (**d**).](nihms484743f4){#F4}

![MiR-17\~92 family miRNAs specifically regulate T~FH~ differentiation beyond the initial phase of T cell activation. (**a**) Expression of miR-17\~92 family miRNAs in naive and *in vitro* activated WT and OX40tKO CD4^+^ T cells were determined by Northern blot (representative of two independent experiments). Numbers indicate miRNA/U6 ratios normalized to naive WT CD4^+^ T cells. (**b--c**) CXCR5^hi^Bcl-6^+^ T~FH~ cells in the spleen were analyzed at day 7 after intraperitoneal (i.p) immunization with OVA+Alum+LPS (n=4\~10 per group). Representative flow cytometry plots are shown in (**b**) and combined bar graphs for T~FH~ are shown in (**c**). (**d--e**) CXCR5^hi^Bcl-6^+^ T~FH~ (**d**) and IFN-γ^+^ T~H~1 cells (**e**) were analyzed at day 8 after LCMV Armstrong infection (n=4\~5 per group). Splenocytes were re-stimulated with gp61 peptide loaded APCs to detect antigen specific IFN-γ^+^ T~H~1 cells. All graphs are shown as means± s.e.m. \*, *p* \< 0.01; n.s., not significant (*p* \>0.05).](nihms484743f5){#F5}

![Deletion of one copy of the *Pten* gene in CD4tKO mice partially restores T~FH~ differentiation. (**a**) The expression of Pten in WT or CD4tKO naive CD4^+^ T cells was examined by immunoblot (upper panel). The lower panel summarizes Pten/β-actin ratios (n=4 per group). (**b**) WT or CD4tKO naive CD4^+^ T cells were stimulated wtih anti-CD3+CD28 for indicated amounts of time and the PI3K pathway was analyzed by immunoblot (representative of three independent experiments). (**c**) The expression of Pten in WT, CD4tKO, or CD4tKO;Pten^fl/+^ naive CD4^+^ T cells was examined by Western blot (left panel). The right panel summarizes Pten/β-actin ratios (n=4 per group). (**d--e**) Flow cytometry analysis of CXCR5^hi^ Bcl-6^+^ T~FH~ (**d**) and FAS^+^GL-7^+^ GCB cells (**e**) in mice of indicated genotypes at day 7 after i.p. immunization with OVA+Alum+LPS (n=9\~12 per group). (**f**) NP-specific IgG1 and IgM antibody concentration was determined by ELISA on days 7, 14 and 21 after i.p immunization with 10 μg NP-CGG+Alum (n=7\~8 per group). All graphs are shown as means± s.e.m. \*, *p* \< 0.05; \*\*, *p* \< 0.01.](nihms484743f6){#F6}

![MiR-17\~92 family miRNAs regulate T~FH~ differentiation through the ICOS-PI3K pathway by suppressing the expression of Phlpp2. (**a**) Predicted miR-17\~92 binding sites in the *Phlpp2* 3′UTR. (**b**) Luciferase reporter assay was performed with WT or mutated R1 and R2 regions and normalized with firefly luciferase activity (Rluc/Fluc). (**c**) naive CD4^+^ T cells were activated with anti-CD3+CD28 and Phlpp2 protein was examined by immunoblot. Rest., CD4^+^ T cells were rested for 2 days in the presence of IL-2 after anti-CD3+CD28 stimulation for 3 days. (**d**) Ly5b^+^ WT or CD4tKO OT-II CD4^+^ T cells were transferred into B6.Ly5a mice. At day 3.5 after OVA+Alum immunization, OT-II CD4^+^ T cells were examined *ex vivo* by intracellular staining of pS6 (n=3\~6 mice per group). (**e**) ICOS-induced pAkt and pS6, and Phlpp2 were examined in pre-activated WT or CD4tKO CD4^+^ T cells by immunoblot. (**f**) Control (RV-CTL) or Phlpp2 shRNA encoding (RV-P2sh) retrovirus transduced WT or CD4tKO OT-II CD4^+^ T cells were adoptively transferred into WT recipient mice, followed by OVA+Alum immunization. CXCR5^hi^Bcl-6^+^ T~FH~ cells were analyzed at day 6\~6.5 post immunization (n=5\~6 per group). (**g--h**) RV-CTL, RV-P2sh, or RV-miR-17\~92 transduced Ly5b^+^ CD4tKO OT-II cells (3x10^6^) (**g**), or RV-CTL, RV-phlpp2 transduced Ly5b^+^ WT OT-II cells (2x10^5^) (**h**) were transferred into Ly5a mice. On day 4 after OVA+Alum immunization, draining lymph nodes were analyzed by immunohistochemistry. Images are representatives of two independent experiments (3\~4 mice per group for each experiment). Scale bar, 70 μm (**g--h**). All graphs are shown as means± s.e.m. \*, *p* \< 0.05; \*\*, *p* \< 0.01.](nihms484743f7){#F7}
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